Animal Healthcare Market (By Animal Type: Production Animal, Companion Animal; By Product: Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, Equipment and Disposables; By Distribution Channel: Retail Pharmacy, E-commerce, Hospital Pharmacy; By End Use; By Treatments) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Animal Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Animal Healthcare Market, by Animal Type, 2023-2032
8.1.1. Production Animal
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Companion Animal
8.1.2.1. Market Revenue and Forecast (2020-2032)
9.1. Animal Healthcare Market, by Product Type, 2023-2032
9.1.1. Vaccines
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Pharmaceuticals
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Feed Additives
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Diagnostics
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Equipment and Disposables
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2020-2032)
10.1. Animal Healthcare Market, by Distribution Channel Type, 2023-2032
10.1.1. Retail Pharmacy
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. E-commerce
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Hospital Pharmacy
10.1.3.1. Market Revenue and Forecast (2020-2032)
11.1. Animal Healthcare Market, by End Use Type, 2023-2032
11.1.1. Reference Laboratories
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Point of care testing/ in-house testing
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Veterinary Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2020-2032)
12.1. Animal Healthcare Market, by Treatments, 2023-2032
12.1.1. Allergies
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Arthritis
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Gastrointestinal Disease
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Difficult Dermatology Cases
12.1.4.1. Market Revenue and Forecast (2020-2032)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2020-2032)
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal (2020-2032)
13.1.2. Market Revenue and Forecast, by Product (2020-2032)
13.1.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.4. Market Revenue and Forecast, by End Use (2020-2032)
13.1.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.1.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.1.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.1.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.1.8.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.4. Market Revenue and Forecast, by End Use (2020-2032)
13.2.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.7. Market Revenue and Forecast, by End Use (2020-2032)
13.2.8. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.10. Market Revenue and Forecast, by End Use (2020-2032)
13.2.11. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.12.4. Market Revenue and Forecast, by End Use (2020-2032)
13.2.13. Market Revenue and Forecast, by Treatments (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Animal (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.2.14.4. Market Revenue and Forecast, by End Use (2020-2032)
13.2.15. Market Revenue and Forecast, by Treatments (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.9. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.10.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Animal (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.3.11.4. Market Revenue and Forecast, by End Use (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.9. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.10.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Animal (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.4.11.4. Market Revenue and Forecast, by End Use (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Animal (2020-2032)
13.5.2. Market Revenue and Forecast, by Product (2020-2032)
13.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.4. Market Revenue and Forecast, by End Use (2020-2032)
13.5.5. Market Revenue and Forecast, by Treatments (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Animal (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.6.4. Market Revenue and Forecast, by End Use (2020-2032)
13.5.7. Market Revenue and Forecast, by Treatments (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Animal (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)
13.5.8.4. Market Revenue and Forecast, by End Use (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Treatments (2020-2032)
14.1. Elanco
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bayer
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Dechra Pharmaceuticals
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Neogen
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Boehringer Ingelheim
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Merck & Co, Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Zoetis
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Nutreco N.V.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Virbac
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Vetquinol S.A.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample